Optimization of the Lowry Method of Protein Precipitation from the H. influenzae Type b Conjugate Vaccine Using Deoxycholic Acid and Hydrochloric Acid |
Kim, Hyun-Sung
(Berna Biotech Korea Corp.)
Kim, Sang-Joon (Berna Biotech Korea Corp.) Kim, Hui-Jung (Berna Biotech Korea Corp.) Kim, Han-Uk (Berna Biotech Korea Corp.) Ahn, Sang-Joem (Berna Biotech Korea Corp.) Hur, Byung-Ki (Department of Biotechnology and Bioengineering, Inha University) |
1 | Lovrien, R. and D. Matulis (2003) Assays for total protein. pp. 18-24. In: J. E. Coligan, B. M. Duun, D. W. Speicher, and P. T. Wingfield (eds.). Short Protocols in Protein Science. John Wiley & Sons, Inc. Canada |
2 | Hartree, E. F. (1972) Determination of protein: A modification of the Lowry method that gives a linear photometric response. Anal. Biochem. 48: 422-427 DOI ScienceOn |
3 | Ward, J. (1991) Prevention of invasive Haemophilus influenzae type b disease: lessons from vaccine efficacy trials. Vaccine 9 Suppl: S17-S24 DOI ScienceOn |
4 | Pittman, M. (1933) The action of type-specific Haemophilus influenzae antiserum. J. Exp. Med. 58: 683-706 DOI |
5 | Onodera, M. (2002) Silicone rubber membrane bioreactors for bacterial cellulose production. Biotechnol. Bioprocess Eng. 7: 289-294 DOI ScienceOn |
6 | Dajani, A. S., B. I. Asmar, and M. C. Thirumoorthi (1979) Systemic Haemophilus influenzae disease: an overview. J. Pediatr. 94: 355-364 DOI |
7 | Lei, Q. P., D. H. Lamb, R. Heller, and P. Pietrobon (2000) Quantitation of low level unconjugated polysaccharide tetanus toxoid-conjugate vaccine by HPAEC/PAD following rapid seperation by deoxycholate/HCl. J. Pharm. Biomed. Anal. 21: 1087-1091 DOI ScienceOn |
8 | Tarr, P. I. and G. Peter (1978) Demographic factors in the epidemiology of Haemophilus influenzae meningitis in young children. J. Pediatr. 92: 884-888 DOI |
9 | Landsteinder, K. (1962) The Specificity of Serologic Reactions. Cambridge, Harvard University Press, Dover Publications, New York, NY, USA |
10 | Todd, J. K. and F. W. Bruhn (1975) Severe Haemophilus influenzae infections. Am. J. Dis. Child. 129: 607-611 DOI |
11 | Bae C. S., S. S. Hong, S. J. Ahn, Y. S. Jang, and B. K. Hur (2005) Importance of the degree of antigen polymerization by detoxification in modulating the immunogenicity of acellular pertussis vaccine. Biotechnol. Bioprocess Eng. 10: 230-235 과학기술학회마을 DOI ScienceOn |
12 | Peterson, G. L. (1983) Determination of total protein. Meth. Enzymol. 91: 95-121 DOI |
13 | Granoff, D. M. and M. Basden (1980) Haemophilus influenzae infections in Fresno County, California: a prospective study of the effects of age, race, and contact with a case on incidence of disease. J. Infect. Dis. 141: 40-46 DOI ScienceOn |
14 | Guo, Y.-Y., R. Anderson, J. McIver, R. K. Gupta, and G. R. Siber (1998) A simple and rapid method for measuring unconjugated capsular polysaccharide (PRP) of Haemophilus influenzae type b in PRP-tetanus toxoid conjugate vaccine. Biologicals 26: 33-38 DOI ScienceOn |
15 | Tsai, C.-M., X.-X. Gu, and R. A. Byrd (1994) Quantification of polysaccharide in Haemophilus influenzae type b conjugate and polysaccharide vaccines by high-performance anion-exchange chromatography with pulsed amperometric detection. Vaccine 12: 700-706 DOI ScienceOn |
16 | Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85 DOI ScienceOn |
17 | Barrett, D. J. (1985) Human immune responses to polysaccharide antigens: an analysis of bacterial polysaccharide vaccines in infants. Adv. Pediatr. 32: 139-158 |
18 | Guidance for Industry, Biological Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May 2001, BP |
19 | Guidance for Industry, Q2B Validation of Analytical Procedure: Methodology, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), November 1996, ICH |
20 | Annand, R. and P. L. Romeo (1976) Protein in food stuffs. Am. Lab. 8: 37-46 |
21 | Markwell, M. A., S. M. Haas, N. E. Tolbert, and L. L. Bieber (1981) Protein determination in membrane and lipoprotein samples; manual and automated procedures. Meth. Enzymol. 72: 296-303 DOI |
22 | Coulehan, J. L., R. H. Michaels, K. E. Williams, D. K. Lemley, C. Q. North, Jr., T. K. Welty, and K. D. Rogers (1976) Bacterial meningitis in Navajo Indians. Public Health Rep. 91: 464-468 |
23 | Kim, H. S., T. H. Yoo, Y. S. Jang, H. Kim, J. Y. Park, B. K. Hur, Y. W. Ryu, and J. S. Kim (2004) An animal model to evaluate the protective efficacy of Haemophilus influenzae type b conjugate vaccines. Biotechnol. Bioprocess Eng. 9: 490-494 DOI ScienceOn |
24 | Yoo, T. H., H. S. Kim, S. S. Park, E. Y. Bang, Y. K. Oh, L. S. Kim, H. Kim, B. K. Hur, Y. W. Ryu, and J. S. Kim (2003) Measurement of free polysaccharide in tetanus toxoid-conjugate vaccine using antibody/ammonium sulfate precipitation. J. Microbiol. Biotechnol. 13: 469-472 |
25 | Dick, W. E. and J. M. Beurret (1989) Glycoconjugates of bacterial carbohydrate antigens: A survey and consideration of design and preparation factors. pp. 48-113. In: J. M. Cruse and R. E. Lewis (eds.). Conjugate Vaccines Contrib. Microb. Immunol. Karger, Switzerland |
26 | Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275 |
27 | Peterson, G. L. (1979) Review of the Folin phenol protein quantitation method of Lowry, Rosebrough, Farr, and Randall. Anal. Biochem. 100: 201-220 DOI ScienceOn |
28 | Beyer, R. E. (1983) A rapid biuret assay for protein of whole fatty tissues. Anal. Biochem. 129: 483-485 DOI ScienceOn |
29 | Cochi, S. L., C. V. Broome, and A. W. Hightower (1985) Immunization of US children with Haemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. J. Am. Med. Ass. 253: 521-529 DOI |
30 | Korea Minimum Requirements of Biological Products (1999) Haemophilus influenzae Type b-Tetanus Toxoid Conjugate Vaccine. pp. 181-190. Korea Food & Drug Administration (KFDA), Seoul, Korea |